![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Monday, December 07, 2015 10:46:14 AM
There is no approval coming, hence why the stock is trending lower. If approval was imminent, BIEL would not be selling off.
Remember, BIEL has received communication from the FDA explaining why approval was not granted. FDA guidelines stipulate written communication must occur at 100 days. This communication is not a FDA 'goal' or an 'objective'...this is an FDA requirement.
The stock is trending lower because as time goes on, it is increasingly apparent the OTC approval was not given and is not coming.
Just think...if FDA approval was coming, do you think the stock would be selling off?
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM